Table:
begin	end	state
1	18	cytoplasmic
19	44	transmembrane
45	52	non-cytoplasmic
53	78	transmembrane
79	85	cytoplasmic
86	107	transmembrane
108	113	non-cytoplasmic
114	142	transmembrane
143	161	cytoplasmic
162	179	transmembrane
180	186	non-cytoplasmic
187	206	transmembrane
207	243	cytoplasmic
244	265	transmembrane
266	276	non-cytoplasmic
277	299	transmembrane
300	309	cytoplasmic
310	329	transmembrane
330	337	non-cytoplasmic
338	361	transmembrane
362	372	cytoplasmic
373	397	transmembrane
398	402	non-cytoplasmic
403	423	transmembrane
424	432	cytoplasmic

Input:
>RR42_RS19610
MPQVHEISKAQRRKAILAATIGNGLEWFDFTVYSFFALIIAKLFFPTGNDLTSFLLTVAT
FGVGFFMRPVGAIVLGVYADRVGRKAALTLTILMMALGTAIIGLAPTYSSIGLWAPALIV
LARLIQGFSAGGEVGGATAFLIEHAPDEERGAYASWQQASQGISFMLGAAMGALVINGLE
PEQIDAWGWRIPFLFGLLIGPVGMYIRSHLEEPPAFEARRAERAASKVKFSPLTQVLRDH
PREVLAGLGVTILWTVCTYVLVFYMPSYAKQQLGLPLGATFQSTALCGAIILVLCPLMGM
LSDRVGRKRMLGTVALIIGVLAYPLFHWLNVSPTTQTLLMVQVILGILLAAFTGPAPAVL
AEQFPTEVRSTGLSLAYNFAVTIFGGFAPLIVTWLIASSGSKLAPAYYVIAAAAISFVAL
LFMHDRTGKPLQ

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server